Cellyan Biotechnology Co., Ltd HKPD
Set alert
1.98 USD -0.21 -9.59%
At close · Oct 30
1.90 -0.08 -4.04%
After hours · Oct 30, 4:00 PM ET
1.84 Day range 2.12
1.92 52-week range 25.40
- YTD
- -87.99%
- 1 year
- -92.14%
- Open
- 2.11
- Prev close
- 2.19
- Mkt cap
- 4.88M
- Vol
- 27.11K
- Avg vol
- 179.47K
- EPS
- -1.38
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 1.84
- High
- 2.12
Financial health
Altman Z-Score
2.53 Grey zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
4 / 9 Average
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C+2 / 5 overall
- DCF 3
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 3
- P/E 1
- P/B 3
Valuation
P/E -11.8×
FY 2023 5y median 2.0× FY 2026
P/S 1.0×
FY 2023 5y median 1.1× FY 2026
P/B 1.4×
FY 2023 5y median 3.4× FY 2026
P/FCF -17.0×
FY 2023 5y median 1.2× FY 2026
EV/EBITDA -45.3×
FY 2023 5y median 9.1× FY 2026
EV/Sales 1.1×
FY 2023 5y median 1.2× FY 2026
FCF Yield -5.9%
FY 2023 5y median 1.0% FY 2026
Profitability
Gross Margin 10.3%
FY 2023 5y median 16.6% FY 2026
Operating Margin -7.4%
FY 2023 5y median 4.5% FY 2026
Net Margin -8.5%
FY 2023 5y median 3.9% FY 2026
ROE -11.9%
FY 2023 5y median 15.4% FY 2026
ROIC -9.2%
FY 2023 5y median 10.4% FY 2026
ROA -8.8%
FY 2023 5y median 7.5% FY 2026
Growth (YoY)
Revenue -33.9%
FY 2023 FY 2026
Operating Income -853.5%
FY 2023 FY 2026
EPS (diluted) -1511.3%
FY 2023 FY 2026
Free Cash Flow -290.0%
FY 2023 FY 2026
Financial Health
Current Ratio 3.9×
FY 2023 5y median 2.7× FY 2026
Quick Ratio 3.7×
FY 2023 5y median 2.5× FY 2026
Debt / Equity 0.1×
FY 2023 5y median 0.5× FY 2026
Net Debt / EBITDA -3.3×
FY 2023 5y median 0.3× FY 2026
Interest Coverage -7.5×
FY 2023 5y median 10.4× FY 2026
Dividends
Dividend Yield 0.0%
FY 2023 5y median 0.0% FY 2026
Payout Ratio 0.0%
FY 2023 5y median 0.0% FY 2026
Annual · latest fiscal year ends 2026-03-31